Xin Lang Cai Jing·2026-02-11 04:43Group 1 - The core point of the article is the unexpected resignation of CSL's CEO Paul McKenzie, with Gordon Neller appointed as interim CEO just before the release of the company's half-year earnings for FY2026, leading to a significant drop in stock price and raising concerns about the company's strategic direction and acquisition valuations [1][2]. - CSL's stock price has been in a downward trend since August of the previous year, primarily due to the announcement of the Seqirus spin-off plan and subsequent downsizing of the R&D team, which led to doubts about the company's decision-making capabilities [2]. - The company is also burdened by a costly acquisition of Vifor for $11.7 billion in 2022, which has faced scrutiny regarding its return on investment and has contributed to operational challenges [2]. Group 2 - Gordon Neller, the new interim CEO, has extensive experience within CSL, having worked for 33 years in various roles, including CFO and president of Seqirus, and is well-acquainted with the company's core business areas [3]. - Neller has been granted full authority by the board to implement necessary reforms, emphasizing that his interim position does not imply a lack of action [3]. - Neller's compensation as interim CEO includes an annual fixed salary of approximately $2 million and a one-time stock award of $4 million, although he will not receive short-term or long-term incentives due to the lack of a fixed term for his position [3].